Investigational Treatment for Type 2 Diabetes
A research study evaluating an investigational medication in adults living with type 2 diabetes who are already taking a stable diabetes regimen.
- Condition
- Type 2 Diabetes
- Age range
- 18–75
Therapeutic area
Metabolic and endocrine research, with a long-standing focus on type 2 diabetes.
Metabolic and endocrine research, with a long-standing focus on type 2 diabetes.
Research in this area helps answer questions that routine care cannot: how investigational treatments behave over time, in whom, and with what safety profile. Every protocol we run in this area is reviewed by an IRB and conducted under Good Clinical Practice guidelines.
A research study evaluating an investigational medication in adults living with type 2 diabetes who are already taking a stable diabetes regimen.
Answers to questions we hear most often.
No referral is required. You are welcome to contact us directly, and we can coordinate with your provider if you would like.
With your permission we can add you to our recruitment database and contact you when a relevant study opens.
A Principal Investigator with relevant clinical experience leads each protocol, supported by trained coordinators.
That depends entirely on the protocol. The study team explains any changes during the informed consent process, before you decide.
Research in this area helps answer questions that routine care cannot: how investigational treatments behave over time, in whom, and with what safety profile. Every protocol we run in this area is reviewed by an IRB and conducted under Good Clinical Practice guidelines.
View all enrolling studies